SCHEMBL3038166

SCHEMBL3038166

O=S(=O)(c1ccccc1Cl)N1CCN(C23CC4CC(CC(C4)C2)C3)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
POLB P06746 1/20 0.55
CHRM4 P08173 4/20 0.47
CCR1 P32246 3/20 0.46
FAAH O00519 5/20 0.45
TSHR P16473 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10723724 0.80 CHRM4 (0.64) ALDH1A1POLBCHRM4FAAHTSHR
SCHEMBL13265518 0.77 CHRM4 (0.42) CHRM4CCR1FAAHHDAC3HDAC4
SCHEMBL13239842 0.77 CHRM4 (0.42) CHRM4CCR1FAAHHDAC3HDAC4
SCHEMBL2956787 0.77 CCR1 (0.65) POLBCHRM4CCR1FAAHTSHR
SCHEMBL14919808 0.75 ALDH1A1 (0.67) ALDH1A1POLBTSHR
SCHEMBL14919987 0.73 ALDH1A1 (0.65) ALDH1A1POLBTSHR
SCHEMBL2954361 0.72 POLB (0.67) ALDH1A1POLBCHRM4TSHRCYP3A4
SCHEMBL7130175 0.72 POLB (0.61) ALDH1A1POLBCHRM4FAAH
SCHEMBL2960543 0.72 CCR1 (0.51) CHRM4CCR1FAAHTSHR
SCHEMBL13239809 0.72 CCR1 (0.51) CHRM4CCR1FAAHHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. 2006-10-05 US claimed
US-7759339-B2 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. (US) 2010-07-20 US disclosed
EP-1866298-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS Takeda San Diego, Inc. (US) 2007-12-19 EP disclosed
WO-2006105127-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2006-10-05 WO disclosed
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors HSD17B1, HSD17B3, HSD17B2 ALDH1A1 82/4885POLB 503/4885CHRM4 4346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.